| 2nd Dec 2013 3:00 pm |
RNS |
Blocklisting Interim Review |
| 22nd Nov 2013 1:42 pm |
RNS |
XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES |
| 19th Nov 2013 7:00 am |
RNS |
NDA for Naloxegol accepted by US FDA |
| 1st Nov 2013 4:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2013 1:45 pm |
RNS |
Director/PDMR Shareholding |
| 31st Oct 2013 7:02 am |
RNS |
US Court Decision in Pulmicort Respules Litigation |
| 31st Oct 2013 7:01 am |
RNS |
Marc Dunoyer Appointed Chief Financial Officer |
| 31st Oct 2013 7:00 am |
RNS |
3rd Quarter Results |
| 30th Oct 2013 9:00 am |
RNS |
Notice of Results |
| 30th Oct 2013 7:00 am |
RNS |
ASTRAZENECA ADVANCES BENRALIZUMAB TO PHASE III |
| 22nd Oct 2013 7:00 am |
RNS |
AstraZeneca starts phase III study for selumetinib |
| 15th Oct 2013 7:00 am |
RNS |
Medimmune acquires Spirogen |
| 7th Oct 2013 7:00 am |
RNS |
MedImmune completes Amplimmune acquisition |
| 1st Oct 2013 4:00 pm |
RNS |
Total Voting Rights |
| 30th Sep 2013 7:01 am |
RNS |
MAA FOR OLAPARIB ACCEPTED BY EMA |
| 27th Sep 2013 7:00 am |
RNS |
MAA APPLICATION FOR NALOXEGOL ACCEPTED |
| 20th Sep 2013 12:54 pm |
RNS |
Fluenz Tetra receives positive CHMP opinion in EU |
| 4th Sep 2013 7:00 am |
RNS |
Starts phase III clinical programme for olaparib |
| 2nd Sep 2013 3:00 pm |
RNS |
Total Voting Rights |
| 27th Aug 2013 7:00 am |
RNS |
MEDIMMUNE ACQUIRES AMPLIMMUNE |
| 1st Aug 2013 4:00 pm |
RNS |
Total Voting Rights |
| 1st Aug 2013 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 1st Aug 2013 7:00 am |
RNS |
Half Yearly Pipeline Update |
| 1st Aug 2013 7:00 am |
RNS |
Half Yearly Report |
| 31st Jul 2013 9:00 am |
RNS |
Notice of Results |
| 31st Jul 2013 7:00 am |
RNS |
Collaborates with FibroGen on anaemia treatment |
| 26th Jul 2013 7:00 am |
RNS |
FDA receipt of dapagliflozin resubmission |
| 19th Jul 2013 7:00 am |
RNS |
AstraZeneca completes acquisition of Omthera |
| 15th Jul 2013 7:00 am |
RNS |
Simon Lowth, CFO, to leave AstraZeneca |
| 11th Jul 2013 4:30 pm |
RNS |
Holding(s) in Company |
| 1st Jul 2013 3:00 pm |
RNS |
Total Voting Rights |
| 28th Jun 2013 5:35 pm |
RNS |
Publication of Prospectus |
| 28th Jun 2013 7:00 am |
RNS |
Completes Acquisition of Pearl Therapeutics |
| 19th Jun 2013 7:00 am |
RNS |
Announces top-line results for SAVOR study |
| 12th Jun 2013 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jun 2013 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jun 2013 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 10th Jun 2013 7:00 am |
RNS |
To Acquire Pearl Therapeutics |
| 4th Jun 2013 7:00 am |
RNS |
Top-line results from Phase III Oskira trials |
| 3rd Jun 2013 1:00 pm |
RNS |
Blocklisting Interim Review |
